News
Patients with rheumatoid arthritis who undergo immune checkpoint inhibition for metastatic non-small cell lung cancer demonstrate similar overall survival as those without RA, according to data ...
Rheumatoid arthritis (RA) is an autoimmune disorder predominantly affecting women, characterized by joint damage and ...
CBS Philadelphia on MSN12d
New research about alternative treatment for people with rheumatoid arthritisThere's a potential new alternative treatment for people with rheumatoid arthritis, an often debilitating condition. Stephanie Stahl reports more about the new research.
A new clinical test may be able to predict which biologic may be the most effective for each individual with rheumatoid arthritis and help take the guesswork out of treatment, a new study suggests.
13d
GlobalData on MSNAqtual secures $31m to commercialise rheumatoid arthritis testThe funding round saw participation from new investors Bold Capital and Bold Longevity Growth Fund, alongside previous ...
The Rheumatoid Arthritis Market value was US$ $$ billion in 2022. The Rheumatoid Arthritis Market value is forecast to reach US$ $$ billion by 2032, growing at a compound annual growth rate (CAGR) $% ...
Some treatments for rheumatoid arthritis could increase cancer risk. One reason is because some cells in our immune system ...
12d
News-Medical.Net on MSNMyopenia identified as key contributor to muscle loss in rheumatoid arthritisRheumatoid arthritis (RA) is a chronic autoimmune disease that affects individuals across all ages and genders.
Discover how targeted therapies are revolutionizing autoimmune disease treatment by offering greater precision.
Patients with rheumatoid arthritis and cancer seek clear information on drug safety, cancer risks, and treatment decisions, a new study finds.
Ahmedabad: Zydus Lifesciences Limited has received final approval from the United States Food and Drug Administration (USFDA) ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results